Skleo Health raises €3.0M Seed round
9 July 2025· Düsseldorf, Germany· health, ophthalmology, digital_health, ai, b2b, pure_software
The funding will be used to scale its network of accessible, medically-validated eye screenings nationwide, fuel the expansion of its partner network with the goal of reaching a capacity of 30,000 screenings per month, build its open, nationwide platform to connect patients with specialist eye doctors, and support further development of Skleo's proprietary AI diagnostic technology.
Investors
LeadSanoptis
Also participating
Antlerangel investorsOHA Beteiligungsgesellschaft
About Skleo Health
Stage
Seed
Headquarters
Düsseldorf, Germany
Founded
2024
Team Size
6–20
Sectors
healthophthalmologydigital_healthaib2bpure_software